相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk factors for severe and critically ill COVID-19 patients: A review
Ya-dong Gao et al.
ALLERGY (2021)
Adults with chronic acid sphingomyelinase deficiency show significant visceral, pulmonary, and hematologic improvements after enzyme replacement therapy with olipudase-alfa: 1-year results of the ASCEND placebo-controlled trial
Melissa Wasserstein et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfa
Bethanie Garside et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Impact and burden of acid sphingomyelinase deficiency from a patient and caregiver perspective
Robin Pokrzywinski et al.
SCIENTIFIC REPORTS (2021)
One-year results of a clinical trial of olipudase alfa enzyme replacement therapy in pediatric patients with acid sphingomyelinase deficiency
George A. Diaz et al.
GENETICS IN MEDICINE (2021)
Prevalence of Cancer in Acid Sphingomyelinase Deficiency
Wladimir Mauhin et al.
JOURNAL OF CLINICAL MEDICINE (2021)
One-year results of the placebo-controlled ASCEND trial of olipudase alfa enzyme replacement therapy in adults with chronic acid sphingomyelinase deficiency
Melissa Wasserstein et al.
MOLECULAR GENETICS AND METABOLISM (2021)
Prospective study of the natural history of chronic acid sphingomyelinase deficiency in children and adults: eleven years of observation
Margaret M. McGovern et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Interstitial lung disease in lysosomal storage disorders
Raphael Borie et al.
EUROPEAN RESPIRATORY REVIEW (2021)
Biochemical and imaging parameters in acid sphingomyelinase deficiency: Potential utility as biomarkers
Eline C. B. Eskes et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Niemann-Pick disease type-B: a unique case report with compound heterozygosity and complicated lipid management
L. Ordieres-Ortega et al.
BMC MEDICAL GENETICS (2020)
Long-term efficacy of olipudase alfa in adults with acid sphingomyelinase deficiency (ASMD): Further clearance of hepatic sphingomyelin is associated with additional improvements in pro- and anti-atherogenic lipid profiles after 42 months of treatment
Beth L. Thurberg et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Clinical relevance of endpoints in clinical trials for acid sphingomyelinase deficiency enzyme replacement therapy
Simon A. Jones et al.
MOLECULAR GENETICS AND METABOLISM (2020)
Preventing infections in children and adults with asplenia
Grace M. Lee
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2020)
Olipudase alfa for treatment of acid sphingomyelinase deficiency (ASMD): safety and efficacy in adults treated for 30 months
Melissa P. Wasserstein et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2018)
The impact of biomarkers analysis in the diagnosis of Niemann-Pick C disease and acid sphingomyelinase deficiency
Federica Deodato et al.
CLINICA CHIMICA ACTA (2018)
Bone health in patients with inborn errors of metabolism
M. Langeveld et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2018)
Recommended vaccinations for asplenic and hyposplenic adult patients
Paolo Bonanni et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
Margaret M. McGovern et al.
GENETICS IN MEDICINE (2017)
Types A and B Niemann-Pick disease
Edward H. Schuchman et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Disease manifestations and burden of illness in patients with acid sphingomyelinase deficiency (ASMD)
Margaret M. McGovern et al.
ORPHANET JOURNAL OF RARE DISEASES (2017)
Acid sphingomyelinase deficiency (Niemann-Pick disease type B) in adulthood: A retrospective multicentric study of 28 adult cases
O. Lidove et al.
REVUE DE MEDECINE INTERNE (2017)
Oxygen therapy for interstitial lung disease: a systematic review
Emily C. Bell et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)
Margaret M. McGovern et al.
GENETICS IN MEDICINE (2016)
Clearance of Hepatic Sphingomyelin by Olipudase Alfa Is Associated With Improvement in Lipid Profiles in Acid Sphingomyelinase Deficiency
Beth L. Thurberg et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)
Cause of death in patients with chronic visceral and chronic neurovisceral acid sphingomyelinase deficiency (Niemann-Pick disease type B and B variant): Literature review and report of new cases
David Cassiman et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Epidemiology and diagnosis of lysosomal storage disorders; challenges of screening
Sandra D. K. Kingma et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Nonclinical safety assessment of recombinant human acid sphingomyelinase (rhASM) for the treatment of acid sphingomyelinase deficiency: The utility of animal models of disease in the toxicological evaluation of potential therapeutics
James M. Murray et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Successful within-patient dose escalation of olipudase alfa in acid sphingomyelinase deficiency
Melissa P. Wasserstein et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Pulmonary rehabilitation for interstitial lung disease
Leona Dowman et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Morbidity and mortality in type B Niemann-Pick disease
Margaret M. McGovern et al.
GENETICS IN MEDICINE (2013)
Small Molecule Inhibitors of Acid Sphingomyelinase
Christoph Arenz
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2010)
A prospective, cross-sectional survey study of the natural history of Niemann-Pick disease type B
Margaret M. McGovern et al.
PEDIATRICS (2008)
Natural history of type a Niemann-Pick disease - Possible endpoints for therapeutic trials
MM McGovern et al.
NEUROLOGY (2006)
The natural history of type B Niemann-Pick disease: Results from a 10-year longitudinal study
MP Wasserstein et al.
PEDIATRICS (2004)
Lipid abnormalities in children with types A and B Niemann Pick disease
MM McGovern et al.
JOURNAL OF PEDIATRICS (2004)
Prenatal diagnosis of Niemann-Pick diseases types A, B and C
MT Vanier
PRENATAL DIAGNOSIS (2002)
Infusion of recombinant human acid sphingomyelinase into Niemann-Pick disease mice leads to visceral, but not neurological, correction of the pathophysiology
SRP Miranda et al.
FASEB JOURNAL (2000)
分享论文
